NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29 [Yahoo! Finance]
Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.
Nurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader Zelebrudomide [Seeking Alpha]
Nurix Therapeutics (NRIX) had its price target lowered by Wells Fargo & Company from $29.00 to $28.00. They now have an "overweight" rating on the stock.
Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $26.00 price target on the stock.
Form 10-Q Nurix Therapeutics, Inc. For: Feb 28
Form 8-K Nurix Therapeutics, Inc. For: Apr 08
Form 4 Nurix Therapeutics, Inc. For: Apr 02 Filed by: Ring Christine
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.